The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2010 by Vanderbilt University.
Recruitment status was Recruiting

Sponsor:

Collaborator:

Information provided by:

Vanderbilt University

ClinicalTrials.gov Identifier:

NCT00603148

First received: October 17, 2007

Last updated: January 6, 2010

Last verified: January 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2008
Estimated Primary Completion Date:	No date given